Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07434752

A Study to See if an Energy Drink With Caffeine and Green Tea Increases Fat Burning When Exercising

The goal of this study is to evaluate the influence of consuming a drink containing a combination of caffeine and green tea extracts on fat oxidation responses at rest, during and after a period of endurance type exercise.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–45 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Griffith University, Gold Coast Campus

Southport, Queensland, 4222, Australia

Location status: Recruiting

About this study

This study investigates whether consuming an energy drink containing caffeine and green tea extract before exercise increases fat burning (oxidation) compared with a placebo drink. Healthy, moderately active adults will attend three visits at clinic over 3-5 weeks. The first visit determines each participant's individual exercise intensity that maximises fat use during cycling. At two subsequent visits, participants will consume either the active drink or a placebo before completing a 30-minute cycling session at their personalised intensity. Fat and carbohydrate use, heart rate, blood pressure, and subjective responses will be measured at rest, during exercise, and after exercise using a double-blind, crossover design.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Passing the Exercise and Sport Science Australia adult pre-exercise screening system (APSS) stage 1 & 2 (see appendix 4).
  • Between the ages of 18 and 45,
  • Not sedentary, and not completing more than 150 minutes of low and/or moderate and/or or vigorous intensity endurance exercise a week,
  • Ability to commit to in principle fulfilment of all 3 trial visits,
  • No history of coagulopathy e.g., DVT, stroke,
  • No known heart disease,
  • No known pancreatic insufficiency,
  • No known inflammatory bowel disease, or prior bowel resection or bypass surgery (excluding gastric banding and sleeve),
  • BMI of 22.0 to 34.9 kg/m2,
  • No known allergies to caffeine or green tea extract,
  • No known type I or II diabetes,
  • No uncontrolled concurrent illness,
  • No known current pregnancy or breastfeeding women
  • No current regular consumption of supplements (>2 times a week) or foods and drinks containing caffeine and/or green tea extracts (>2 times per day, weekly).
  • Agree not to consume caffeine for 12-hours prior to the clinic visit.

Exclusion criteria

  • Triggering any of the exclusion screening criteria as outlined below, and in compliment with the Exercise and Sport Science Australia adult pre-exercise screening system (APSS).
  • Under the age of 18 or over the age of 45,
  • Sedentary, or completing over 150 minutes of low and/or moderate and/or or vigorous intensity endurance exercise a week,
  • Inability to commit to in principle fulfilment of all 3 trial visits,
  • History of coagulopathy e.g., DVT, stroke,
  • Known heart disease,
  • Known pancreatic insufficiency,
  • Known inflammatory bowel disease, or prior bowel resection or bypass surgery (excluding gastric banding and sleeve),
  • BMI < 22.0 or > 34.9 kg/m2,
  • Known allergies to caffeine or green tea extract,
  • Known type I or II diabetes,
  • Uncontrolled concurrent illness,
  • Taking GLP-1 agonists, caffeine, or any other medication known to affect metabolism.
  • Known current pregnancy or breastfeeding women.
  • Currently regularly consuming supplements, foods or drinks containing a caffeine and green tea extract blend, or not willing to abstain for the study

Treatment and study plan

Active (Green tea and caffeine)

Dietary Supplement

Two 355 mL cans of "XS Energy + BURN" drink containing caffeine and green tea extract.

Other names: XS Energy + BURN

Placebo

Other

Two 355 mL cans of placebo drink but without the active ingredients (caffeine and green tea extract).

Primary outcomes

  1. Fat oxidation as measured by indirect calorimetry

    Time frame: Baseline to 30 mins post exercise

    Change from baseline to the end of the study period in Fat oxidation as measured by indirect calorimetry (metabolic cart); baseline (pre-drink), post-drink (pre-exercise), time sequence e.g., every 5-min during exercise, 10, 20 and 30-min post-exercise. Change from baseline & total. Fat oxidation will be measured continuously throughout the exercise and the 30-min post-exercise window, to facilitate total, and any other temporal fat oxidation timepoints.

Secondary outcomes

  1. Carbohydrate oxidation; indirect calorimetry

    Time frame: Baseline to 30 mins post exercise

    Change from baseline to the end of the study period in Carbohydrate oxidation; indirect calorimetry; same timing as fat oxidation (baseline (pre-drink), post-drink (pre-exercise), time sequence e.g., every 5-min during exercise, 10, 20 and 30-min post-exercise.). Change from baseline & total.

  2. Respiratory exchange ratio; indirect calorimetry

    Time frame: Baseline to 30 mins post exercise

    Change from baseline to the end of the study period in Respiratory exchange ratio; indirect calorimetry; same timing as fat oxidation (baseline (pre-drink), post-drink (pre-exercise), time sequence e.g., every 5-min during exercise, 10, 20 and 30-min post-exercise). Change from baseline & total

  3. Exercise efficiency; indirect calorimetry

    Time frame: Baseline to 30 mins post exercise

    Change from baseline to the end of the study period in Exercise efficiency; indirect calorimetry; time sequence during exercise e.g., every 5-min. Change from the beginning of exercise & average

Other outcomes

  1. Tertiary: Compliance monitoring

    Time frame: Baseline to end of study period (week 5)

    Compliance monitoring for adherence to clinical trial components e.g. consumed volume of investigational product; ability to complete the necessary duration (30 mins) and intensity (at fat max) of exercise; adherence to immediate pre-trial control procedures of no caffeine or green tea extract in the 12 hours leading up to the experimental, arrival at the laboratory after an overnight fast

  2. Tertiary: Adverse Event monitoring

    Time frame: Baseline to end of study period (week 5)

    Adverse events will be monitored throughout the study across the study periods.

  3. Tertiary: Perceived gastrointestinal (dis)comfort questionnaire

    Time frame: Baseline to end of study (week 5)

    Change from baseline to the end of the study period in Perceived gastrointestinal (dis)comfort; measured via a questionnaire.

  4. Tertiary: Perceived satiety / hunger

    Time frame: Baseline to end of study period (week 5)

    Change from baseline to the end of the study period in Perceived satiety / hunger; measured via questionnaire.

  5. Tertiary: Perceived exercising exertion

    Time frame: Baseline to end of study period (week 5)

    Change from baseline to the end of the study period in Perceived exercising exertion; measured via questionnaire.

  6. Tertiary: heart rate

    Time frame: Baseline to end of study period (week 5)

    Change from baseline to the end of the study period in heart rate. Pre, during and post exercise heart rate.

  7. Tertiary: blood pressure

    Time frame: Baseline to end of study period (week 5)

    Change from baseline to the end of the study period in blood pressure. Pre, during and post exercise blood pressure.

  8. Tertiary: Safety via AE monitoring

    Time frame: Baseline to end of study period (week 5)

    Change from baseline to the end of the study period in safety via AE monitoring.

  9. Tertiary: Anthropometry - BMI

    Time frame: Baseline to end of study period (week 5)

    Change from baseline to the end of the study period in BMI.

  10. Tertiary: Anthropometry - weight

    Time frame: Baseline to end of study period (week 5)

    Change from baseline to the end of the study period in weight.

  11. Tertiary: Anthropometry - waist circumference

    Time frame: Baseline to end of study period (week 5)

    Change from baseline to the end of the study period in waist circumference.

Study contacts

Contact information is provided by the study sponsor or research team.

Llion Roberts, PhD

CONTACT

[email protected]

+61755528451

Sponsors and collaborators

Lead sponsor

RDC Clinical Pty Ltd

Industry

Collaborators

  • Amway Corp

Registry information

Official study title

Influence of Caffeine and Green Tea Extracts Consumption on Basal, Peri- and Post-exercise Fat Oxidation

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Feb 27, 2026
Registry last updated
Apr 16, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.